
Pre-Commercial Biotech, Medtech and Digital Health
We partner with global early-stage companies across diverse therapeutic areas.
With our proven expertise, we drive U.S. commercialization and technology enablement, accelerating time to market while mitigating regulatory risks. Our solutions prioritize compliance, security, and cost-effectiveness.
Discover how our tailored services can propel your unique product launch to market success.
a priori FLP is a Unique Hands-On, Brain-Trust
a priori
Forward Launch Partners
Our leadership team brings over 30 years of hands-on experience as C-suite executives in US, UK, and EU life sciences startups, successfully launching innovative products globally.
This brain trust extends to our work with European governments, helping international SMEs establish thriving US operations.
Leveraging this expertise, we developed our proprietary First Launch Partner (FLP) approach and provide hands-on services to execute your portfolio company's successful US market entry.

Priorities for Companies Entering the US Market
We know where SME anxieties lie:
-
Time is money – Evidence, validation, clearance, MVP takes time…minimizing the margins for decision error is critical
-
Race to Revenue – The sooner product-market fit is realized, the sooner you can show evidence of customer traction
-
Positioning for long-term success – Early adoption is important, but equally, if not more important, is building a sustainable foundation for growth.
Gain a Commercial Lens Early
Our team of experts has extensive commercialization experience, filling an often missing gap for new ventures.
As a trusted partner to both life science companies and investors, our services evolve with our clients, ensuring seamless end-to-end solutions throughout the entire company lifecycle.
We act as your executives to ensure a successful U.S. launch—whether you're a US or international early stage company expanding into the U.S.
-
End-to-End U.S. Product Launch Execution – From regulatory approvals to first revenue
-
Fractional CCO & CIO Leadership – Complete Commercial & IT strategy and execution
-
Regulatory Navigation & FDA Approval Acceleration – Including Breakthrough Designation strategy
-
Market Entry Strategy & Commercial Operations Setup – Building U.S. teams, partnerships, and distribution channels
-
Investor-Ready Business & Financial Plans – Pitch decks, valuations, and fundraising strategies
-
Go-to-Market Execution – Including pricing, market access, and payer strategy
-
IT & Digital Transformation for Biotech Scale-Up

Let's talk
If you're launching a biotech product in the U.S. and want proven leaders to de-risk, accelerate, and execute your market entry, let’s talk.
Your Success, Our Mission
1. The Advantage of Being FirstFirst-to-Market: Leading the way
in the competitive world of Life Sciences, being first-to-market is more than an achievement—it’s a transformative opportunity. Launching early establishes your product as the benchmark, giving healthcare professionals and patients a trusted solution. By taking the lead, your brand sets the stage for long-term success, shaping market expectations and creating a foundation for sustained growth.

2. Strategic Partnerships for Success: Relationships That Drive Innovation
The most successful Life Sciences launches are built on trust and collaboration. Securing early partnerships—whether with key healthcare providers, regulatory agencies, or influential stakeholders—can accelerate adoption and build credibility. Strong relationships pave the way for impactful launches, ensuring that your product reaches those who need it most, faster and more effectively.
3. A Culture of Excellence: Innovating with Precision and Purpose
Launching a new Life Sciences product demands an unwavering commitment to quality and innovation. By fostering a culture focused on rigorous research, seamless execution, and adaptability, your company can navigate challenges with confidence. This commitment to excellence ensures that every aspect of your product launch resonates with the highest standards of care and trust.